KMS Medisurgi has scheduled a Board of Directors meeting for September 5, 2026. The gathering will focus on approving the financial statements for the fiscal year ended March 31, 2026.

The company informed the Bombay Stock Exchange about the upcoming session on August 27, 2026. This disclosure aligns with Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Agenda Highlights

The board will transact several key items during the session. These include:

• Approving the Directors' Report for FY26
• Recommending the Financial Statements for member adoption
• Considering the Management Discussion and Analysis Report
• Deciding on the final dividend recommendation for equity shares
• Setting dates for the closure of the Register of Members and Share Transfer Books

Additionally, the board will appoint a Scrutinizer for the voting process at the 28th Annual General Meeting. The directors will also determine the day, date, time, and venue for convening this AGM.

Procedural Details

Siddharth Kanakia, Managing Director of KMS Medisurgi, signed the intimation letter. The company is headquartered in Mumbai. No financial figures were disclosed in this preliminary notice.

KMS Medisurgi Limited reported a 44.2% decline in net profit to ₹24.55 lakh for the financial year ended March 31, 2026, down from ₹43.98 lakh in the previous year. Revenue from operations decreased by 12.4% to ₹1,220.85 lakh compared to ₹1,393.86 lakh in FY25. The company's Board of Directors approved the audited standalone financial results at a meeting held on May 30, 2026.

The decline in profitability was driven by a rise in total expenses, which stood at ₹1,188.84 lakh for the year, alongside a significant drop in other income to ₹1.03 lakh from ₹2.87 lakh. Employee benefits expense increased to ₹130.45 lakh from ₹119.71 lakh, while finance costs rose to ₹10.64 lakh from ₹8.30 lakh. Earnings per share (EPS) for the year stood at ₹0.74, down from ₹1.33 in the previous year.

Qualified Opinion

Statutory auditors H H Dedhia & Associates issued a qualified opinion on the financial results. The report highlighted that the company provided for post-employment benefits on an accrual basis using a group gratuity report from LIC, which constitutes a departure from Accounting Standard (AS) 15. The auditors noted that the absence of an actuarial report prevents the quantification of the deviation.

Additionally, the auditors stated they were unable to comment on the movement of stock and the value of closing stock, recorded at ₹253.80 lakh, due to ongoing reconciliation of stock records with the books of accounts. The management is in the process of maintaining records for material items, and any discrepancies will be accounted for upon identification.

Financial Position

The company's total assets increased to ₹1,054.80 lakh as of March 31, 2026, from ₹1,034.21 lakh a year earlier. Current assets rose to ₹732.12 lakh, driven by an increase in cash and cash equivalents to ₹110.47 lakh from ₹46.73 lakh. Trade receivables, however, decreased to ₹322.22 lakh from ₹424.11 lakh.

On the liabilities side, shareholders' funds improved to ₹831.48 lakh from ₹808.58 lakh. Long-term borrowings reduced to ₹77.34 lakh from ₹91.28 lakh. Current liabilities increased to ₹145.98 lakh, with trade payables rising to ₹125.90 lakh.

Cash Flow Analysis

Net cash generated from operating activities more than doubled to ₹151.34 lakh in FY26 from ₹73.78 lakh in the previous year. Cash flow used in investing activities was ₹61.38 lakh, primarily due to capital expenditure. The company reported a net cash outflow from financing activities of ₹26.23 lakh, resulting from the repayment of borrowings and dividend distribution. Consequently, cash and cash equivalents increased to ₹110.47 lakh at the end of the year.